scispace - formally typeset
D

Dalibor Pacík

Researcher at Masaryk University

Publications -  85
Citations -  936

Dalibor Pacík is an academic researcher from Masaryk University. The author has contributed to research in topics: Renal cell carcinoma & Cancer. The author has an hindex of 16, co-authored 85 publications receiving 753 citations.

Papers
More filters
Journal ArticleDOI

Rezūm System Water Vapor Treatment for Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia: Validation of Convective Thermal Energy Transfer and Characterization With Magnetic Resonance Imaging and 3-Dimensional Renderings.

TL;DR: This imaging study confirms the delivery of convective water vapor technology to create thermal lesions in the prostate tissue with near complete resolution by 3 and 6 months after treatment with a concomitant one-third reduction in overall prostate and transition zone volumes.
Journal ArticleDOI

Efficacy and Safety of Rezūm System Water Vapor Treatment for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia

TL;DR: The Rezūm System provides effective relief of LUTS associated with BPH at 1 year and the procedure is safe with an acceptable side effect profile.
Journal ArticleDOI

Combination of MiR-378 and MiR-210 Serum Levels Enables Sensitive Detection of Renal Cell Carcinoma.

TL;DR: Serum microRNAs miR-378 andMiR-210 proved their potential to serve as powerful non-invasive diagnostic and prognostic biomarkers in RCC by demonstrating significantly increased serum levels and significantly decreased levels in the time period of three months after radical nephrectomy.
Journal ArticleDOI

Overexpression of long non-coding RNA TUG1 predicts poor prognosis and promotes cancer cell proliferation and migration in high-grade muscle-invasive bladder cancer

TL;DR: The study confirmed overexpression of Tug1 in MIBC tumor tissue and described its association with worse overall survival in high-grade MIBC patients, suggesting an oncogenic role of TUG1 and its potential usage as biomarker or therapeutic target in MI BC.
Journal ArticleDOI

Two-year results after convective radiofrequency water vapor thermal therapy of symptomatic benign prostatic hyperplasia.

TL;DR: The Rezūm System convective RF thermal therapy is a minimally invasive treatment for BPH/LUTS which has no discernable effect on sexual function and provides significant improvement of LUTS that remain durable at 2 years.